Primary Cutaneous Aspergillosis in a Patient with CARD9 Deficiency and Aspergillus Susceptibility of Card9 Knockout Mice
- 12 November 2020
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 41 (2) , 427-440
Abstract
Purpose We describe a case of primary cutaneous aspergillosis caused by Aspergillus fumigatus, and elucidate the underlying genetic and immunological mechanisms. Materials and Methods Routine clinical and laboratory investigations were performed. Whole-exome sequencing of the patient’s DNA suggested the presence of a CARD9 mutation, which was confirmed by Sanger sequencing. Innate and adaptive immunological responses of patient-derived CARD9-deficient cells were evaluated with ELISA and flow cytometry. Cutaneous and pulmonary aspergillosis models were established in Card9 knockout (KO) mice, which were compared with wild-type and immunosuppressed mice, to explore the pathogenesis and Aspergillus susceptibility. Results A 45-year-old man presented with a 37-year history of skin lesions on his face. A diagnosis of primary cutaneous aspergillosis was made through histopathology, immunohistochemistry, and tissue culture. Sanger sequencing of CARD9 showed a homozygous frame-shift mutation (c.819_820insG, p.D274fsX60), which led to the lack of CARD9 expression. Peripheral blood mononuclear cells from the patient showed selective impairment of proinflammatory cytokines, and Th1-, Th17-, and Th22-associated responses upon fungus-specific stimulation. The cutaneous aspergillosis model established in Card9 KO mice presented with persistent infection, with fungal germs and short hyphae in tissue, consistent with the patient’s lesions. Skin lesions in immunosuppressed mice were more severe, and led to death. Unlike our patient, Card9 KO mice were relatively susceptible to pulmonary aspergillosis, with reasons to be investigated. Conclusions This is, to our knowledge, the first report that links cutaneous aspergillosis to CARD9 mutation. This work enriches both the phenotypic spectrum of CARD9 deficiencies and the genetic background of cutaneous aspergillosis.Keywords
Funding Information
- National Natural Science Foundation of China (NSFC No. 81872539)
- International Cooperation and Exchange Programme (NSFC No. 81520108026)
This publication has 50 references indexed in Scilit:
- Inherited CARD9 Deficiency in 2 Unrelated Patients With Invasive Exophiala InfectionThe Journal of Infectious Diseases, 2014
- Morphological Findings of Deep Cutaneous Fungal InfectionsThe American Journal of Dermatopathology, 2014
- CARD9 Deficiency and Spontaneous Central Nervous System Candidiasis: Complete Clinical Remission With GM-CSF TherapyClinical Infectious Diseases, 2014
- CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficienciesJournal of Allergy and Clinical Immunology, 2014
- Deep Dermatophytosis and Inherited CARD9 DeficiencyNew England Journal of Medicine, 2013
- Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiencyBlood, 2013
- Hypoxia and Fungal Pathogenesis: To Air or Not To Air?Eukaryotic Cell, 2012
- Species-Specific Recognition of Aspergillus fumigatus by Toll-like Receptor 1 and Toll-like Receptor 6The Journal of Infectious Diseases, 2012
- Dectin-1-Dependent Interleukin-22 Contributes to Early Innate Lung Defense against Aspergillus fumigatusInfection and Immunity, 2012
- A HomozygousCARD9Mutation in a Family with Susceptibility to Fungal InfectionsNew England Journal of Medicine, 2009